RHOA mutant (G17V), a loss-of-function mutation, has been identified in both AITL (53–71%) and PTCL-NOS (8–18%) [5, 19, 20]. This evidence concerns the gene RHOA and mature T-cell and NK-cell non-Hodgkin lymphoma.